Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.

about

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.

P2860

Q49888021-DEE0EC24-C0C0-4E28-A7ED-A3BF875AD67D

P2860

Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.

Item

http://www.wikidata.org/entity/Q47139045

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Quizartinib (AC220) reverses A ...... In vitro and in vivo studies.

@en

Quizartinib

@nl

type

Item

label

Quizartinib (AC220) reverses A ...... In vitro and in vivo studies.

@en

Quizartinib

@nl

prefLabel

Quizartinib (AC220) reverses A ...... In vitro and in vivo studies.

@en

Quizartinib

@nl

P1476

Quizartinib (AC220) reverses A ...... In vitro and in vivo studies.

@en

P2093

Jun Li

http://www.w3.org/2001/XMLSchema#string

Kanav Gupta

http://www.w3.org/2001/XMLSchema#string

Louis D Trombetta

http://www.w3.org/2001/XMLSchema#string

Nagaraju Anreddy

http://www.w3.org/2001/XMLSchema#string

Priyank Kumar

http://www.w3.org/2001/XMLSchema#string

Tanaji T Talele

http://www.w3.org/2001/XMLSchema#string

Yanglu Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Jun Wang

http://www.w3.org/2001/XMLSchema#string

Yun-Kai Zhang

http://www.w3.org/2001/XMLSchema#string

Zhe-Sheng Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11)

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10)

The human ATP-binding cassette (ABC) transporter superfamily

Multidrug resistance in cancer: role of ATP-dependent transporters

The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions

Targeting multidrug resistance in cancer

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).

P304

93785-93799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21078

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29212189

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5706835

http://www.w3.org/2001/XMLSchema#string

Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.

about

P2860

P2860

Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932